Founder And Ceo (Techstars / Cdl Comp Health)
CurrentGenerable is on a mission to bring more clarity to early drug development programs starting with oncology. We use the latest advances in Bayesian and causal Inference, machine learning, and probabilistic computing to answer questions about dosing, toxicity, patient and biomarker selection, and efficacy relative to competitive products and standard of care. We have a curated dataset of patient-level data and published research to inform our models. Generable originated from the open-source Stan (mc-stan.org) project at Columbia University.